Sphingoid base metabolism in yeast: mapping gene expression patterns into qualitative metabolite time course predictionsRADIVOYEVITCH, Tomas.Comparative and functional genomics. 2001, Vol 2, Num 5, pp 289-294, issn 1531-6912Article

Biochemical systems analysis of genome-wide expression dataVOIT, Eberhard O; RADIVOYEVITCH, Tomas.Bioinformatics (Oxford. Print). 2000, Vol 16, Num 11, pp 1023-1037, issn 1367-4803Article

A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemiaJACKSON, Robert C; RADIVOYEVITCH, Tomas.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 765-776, issn 0344-5704, 12 p.Article

The risk of chronic myeloid leukemia: Can the dose-response curve be U-shaped?RADIVOYEVITCH, Tomas; KOZUBEK, Stanislav; SACHS, Rainer K et al.Radiation research. 2002, Vol 157, Num 1, pp 106-109, issn 0033-7587Article

Schedule-dependent drug effects of oral 5-lodo-2-pyrimidinone-2'-deoxyribose as an in vivo radiosensitizer in U251 human glioblastoma xenograftsSEO, Yuji; TAOYAN; SCHUPP, Jane E et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7499-7507, issn 1078-0432, 9 p.Article

RADIOSENSITIZATION OF HUMAN CERVICAL CANCER CELLS BY INHIBITING RIBONUCLEOTIDE REDUCTASE: ENHANCED RADIATION RESPONSE AT LOW-DOSE RATESKUNOS, Charles A; COLUSSI, Valdir C; PINK, John et al.International journal of radiation oncology, biology, physics. 2011, Vol 80, Num 4, pp 1198-1204, issn 0360-3016, 7 p.Article

A phase I and pharmacodynamic study of Fludarabine, carboplatin, and topotecan in Patients with relapsed, refractory, or high-risk acute leukemiaCOOPER, Brenda W; VEAL, Gareth J; GOSKY, David et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 6830-6839, issn 1078-0432, 10 p.Article

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancerCOOPER, Brenda W; RADIVOYEVITCH, Tomas; OVERMOYER, Beth A et al.Breast cancer research and treatment. 2006, Vol 97, Num 3, pp 311-318, issn 0167-6806, 8 p.Article

Cardiovascular safety profile of combretastatin A4 phosphate in a single-dose Phase I study in patients with advanced cancerCOONEY, Matthew M; RADIVOYEVITCH, Tomas; STAMBLER, Bruce S et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 96-100, issn 1078-0432, 5 p., 1Article

Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex^® systemCOLLIE, Angela M. B; NÖLLING, Jörk; DALY, Thomas et al.British journal of haematology. 2014, Vol 167, Num 2, pp 281-285, issn 0007-1048, 5 p.Article

Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitizationTAVERNA, Pietro; HWANG, Hwa-Shin; SCHUPP, Jane E et al.Cancer research (Baltimore). 2003, Vol 63, Num 4, pp 838-846, issn 0008-5472, 9 p.Article

Reduced expression of NFAT-associated genes in UCB versus adult CD4⁺ T lymphocytes during primary stimulationKAMINSKI, Beth A; KADEREIT, Suzanne; MILLER, Robin E et al.Blood. 2003, Vol 102, Num 13, pp 4608-4617, issn 0006-4971, 10 p.Article

p53-Independent, Normal Stem Cell Sparing Epigenetic Differentiation Therapy for Myeloid and Other Malignancies : MOLECULAR PATHOGENESIS OF HEMATOLOGIC MALIGNANCIESSAUNTHARARAJAH, Yogen; TRIOZZI, Pierre; COPELAN, Ed et al.Seminars in oncology. 2012, Vol 39, Num 1, pp 97-108, issn 0093-7754, 12 p.Article

A Novel Data-Driven Prognostic Model for Staging of Colorectal CancerMANILICH, Elena A; KIRAN, Ravi P; RADIVOYEVITCH, Tomas et al.Journal of the American College of Surgeons. 2011, Vol 213, Num 5, pp 579-588, issn 1072-7515, 10 p.Article

Inflammatory breast cancer as a model disease to study tumor angiogenesis : Results of a phase IB trial of combination SU5416 and doxorubicinOVERMOYER, Beth; PINGFU FU; ABDUL-KARIM, Fadi W et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5862-5868, issn 1078-0432, 7 p.Article